All News

Pharmacists can help to reduce the prevalence of food insecurity and its negative health care outcomes by tailoring clinical care to each individual patient’s needs.

At week 16, 56.4% of patients receiving tofacitinib achieved an Assessment in SpondyloArthritis International Society 20 response.

Patients with hormone receptor-positive breast cancer doubled their median progression-free survival following a switch to fulvestrant plus palbociclib.

Patients with breast cancer treated with pyrotinib plus capecitabine had a 31% lower risk of death than those treated with lapatinib and capecitabine

New technology provides information on the benefit of adding atezolizumab to chemotherapy as a neoadjuvant treatment for patients with early high-risk and locally advanced triple-negative breast cancer.

18th-century German Swedish chemist Carl Wilhelm Scheele’s biggest claims to fame are chlorine, manganese, and oxygen.

Zofran aids in the prevention of nausea and vomiting.

Experts reviewed the efficacy and safety of the recommended treatment regimens and discussed which treatment strategy they would recommend for their patients.

Some minor skin wounds may heal faster when an antibiotic is applied to the affected area.

Gastrointestinal bleeding can range from mild to severe and can be life-threatening.

In specialty pharmacy, many patients take steps to manage their prescription benefits before the new year.

NRx Pharmaceuticals announces that no new concerns were identified by an independent data safety monitoring board, which recommends continued enrollment.

However, active disease alone for hospitalized patients was not associated with greater odds of dying from COVID-19, nor was receiving ongoing cancer treatment.

Uterine cancers that developed in patients with breast cancer treated with tamoxifen had fewer phosphoinositol-3-kinase (PI3K) pathway mutations and may have been driven by tamoxifen-induced PI3K pathway activation.

Data from a couple of new molecules could be encouraging for the treatment of acute myeloid leukemia and diffuse large B-cell lymphoma

The findings are consistent with an interim analysis showing that the drug significantly reduced the risk of hospitalization or death for any cause by 89% compared with the placebo.

Since its initial approval in 2016 for urothelial carcinoma, atezolizumab has received FDA approval for an additional 5 types of carcinomas.

Technology, COVID-19, and scope expansion—here’s how pharmacists can capitalize on opportunities coming in the new year.

Serotypes 22F, 33F, and 3 represent more than a quarter of invasive pneumococcal disease in children under the age of 5

Offering individual advice and counseling to patients can help combat the risks of driving under the influence of prescription drugs.

In addition to data showing the durable efficacy of acalabrutinib, other data presented at ASH 2021 demonstrate that the new tablet formulation of the drug supports ease of use for patients

Emicizumab-kxwh demonstrated a favorable safety profile and effective bleed control in people with mild or moderate hemophilia A without factor VIII inhibitors.

The study demonstrates a need for novel tolerable and efficacious therapeutic agents to address the burden of illness in patients with multiple myeloma, according to the investigators.

The study examined safety, immune response (immunogenicity), and adverse effects of 7 vaccines when used as a third booster jab.

The data presented shows that at 16 weeks, individuals who added the atopic dermatitis drug to low potency standard-of-care topical corticosteroids experienced 28% achieved clear or almost-clear skin.

Dermoplast offers short-term relief of pain and itching from certain skin conditions, such as sunburn, scrapes, and insect bites.

Pharmacists have an important role in the optimization of AML therapies.

Gabapentin enacarbil treats moderate-to-severe primary restless leg syndrome and postherpetic neuralgia.

GERD is mild acid reflux that occurs at least twice a week or moderate to severe acid reflux that occurs at least once a week.

Study results show that clonal hematopoiesis of indeterminate potential is associated with a lower likelihood of developing AD.